Streetbeat News

Regulatory

BTCUSD

GBTC

Peter Schiff, a gold investor, has warned that the current Bitcoin rally could peak if the Grayscale Bitcoin Trust (GBTC) is approved to convert into an ETF by the SEC. He suggests that a potential selloff could occur if this conversion takes place. This comes as the SEC and Grayscale's dispute over the approval of a spot bitcoin ETF has concluded, with the D.C. Circuit Court of Appeals directing the SEC to abandon its rejection of Grayscale's application.

Portfolio Pulse from Mehab Qureshi

October 24, 2023 | 12:00 pm

TSLA

Tesla's former CFO Zachary Kirkhorn may have been fired rather than resigned, according to Future Fund Managing Partner and Tesla investor Gary Black. This speculation is based on a severance agreement found in Tesla's third-quarter earnings report. The severance agreement suggests termination rather than resignation. The reason for the potential firing could be disagreement on pricing philosophy, as Tesla has been aggressively cutting prices, leading to margin erosion and a double miss in the third quarter.

Portfolio Pulse from Shanthi Rexaline

October 24, 2023 | 11:52 am

FXI

SPY

China has removed Li Shangfu from his position as Defense Minister, according to Chinese state media reports cited by Reuters. The impact on US-listed ETFs such as FXI and SPY is yet to be determined.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:16 am

AZN

The US Food and Drug Administration (FDA) has accepted AstraZeneca's supplemental biologics license application for self-administration of FLUMIST QUADRIVALENT (Influenza Vaccine Live, Intranasal).

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:07 am

IMTX

Immatics has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for its ACTengine IMA203 TCR-T monotherapy. This designation will expedite the development and review of the therapy.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:05 am

MIST

Milestone Pharmaceuticals has submitted a New Drug Application (NDA) to the FDA for Etripamil.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:05 am

MRNA

Moderna has announced that the first participant has been dosed in a Phase 3 study of mRNA-1083, a combination vaccine against Influenza and COVID-19.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:04 am

BMY

Bristol Myers Squibb has announced that its investigational LPA1 antagonist has been granted Breakthrough Therapy Designation by the U.S. FDA for the treatment of progressive pulmonary fibrosis.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2023 | 11:03 am

BTCUSD

Venture capitalist Chamath Palihapitiya declared Bitcoin (CRYPTO: BTC) dead in America in April 2023, when it was trading at $27,817.50. Despite this, Bitcoin has continued to persevere, reaching $34,522 recently. This increase was influenced by the news that BlackRock's iShares Bitcoin Trust ETF has been added to the Depository Trust and Clearing Corporation's curated list, indicating progress towards its launch. If one had invested $100 in Bitcoin when Palihapitiya made his statement, they would have seen a 22% increase in their investment today.

Portfolio Pulse from Mehab Qureshi

October 24, 2023 | 10:30 am

MSFT

Vivian Schiller, former global news chair of Twitter and executive director of Aspen Digital, criticized Elon Musk's X (formerly Twitter) for spreading misinformation during the Israel-Hamas conflict. She also commented on the misuse of verified checkmarks on X and a recent incident involving Microsoft's LinkedIn where a website scraped information to identify employees expressing anti-Israel opinions. An alarming report by News Guard found that 74% of the most circulated posts containing misinformation on X were boosted by users with blue checkmarks.

Portfolio Pulse from Ananya Gairola

October 24, 2023 | 10:16 am